Repeated exposure to Δ9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat

Neuroscience Letters

Volumn 246, Issue 3, 1998, Pages 169-172

  Jentsch, J David ^a   D Verrico, Christopher ^a   Le, Dung ^a   Roth, Robert H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabis; Dihydroxy O phenyl acetic acid; Dopamine; Marijuana; Nucleus accumbens; Prefrontal cortex; Striatum

Indexed keywords

CANNABIS; DRONABINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; WORKING MEMORY;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; MALE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROCANNABINOL; TIME;

EID: 0032502590     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00254-7     Document Type: Article

References (20)

1. Brozoski T.J., Brown R.M., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 205:1979;929-931.
2. Daniel D.G., Weinberger D.R., Jones D.W., Zigun J.R., Coppola R., Handel S., Bigelow L.B., Goldberg T.E., Berman K.F., Kleinman J.E. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J. Neurosci. 11:1991;1907-1917.
3. Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry. 148:1991;1474-1486.
4. Deutch A.Y. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J. Neural Transm. (Suppl.). 36:1991;61-89.
5. Deutch, A.Y. and Roth, R.H., The determinants of stress-induced activation of the prefrontal cortical dopamine system. In H.B.M. Vylings, C.C. van Eden, J.P.C. DeBruim, M.A. Corner, M.G.P. Feenstra (Eds.), The Prefrontal Cortex: Its Structure, Function and Pathology, Progress in Brain Research, Vol. 85, Elsevier, Amsterdam, 1990, pp. 367-403.
6. Dolan R.J., Fletcher P., Frith C.D., Friston K.J., Frackowiak R.S.J., Grasby P.M. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature. 378:1995;180-182.
7. Fey E.T. The performance of young schizophrenics and young normals on the Wisconsin Card Sorting Test. J. Consult. Psychol. 15:1951;311-319.
8. Goldman-Rakic, P.S., Prefrontal cortical dysfunction in schizophrenia: the relevance of working memory. In B.J. Carroll, J.E. Barrett (Eds.), Psychopathology and the Brain, Raven Press, New York, 1991, pp. 1-23.
9. Goldman-Rakic, P.S., Bergson, C., Mrzljak, L. and Williams, G.V., Dopamine receptors and cognitive function in nonhuman primates. In K.A. Neve and R.L. Neve (Eds.), The Dopamine Receptors, Humana Press, Tuscon, AZ, 1996, pp. 499-522.
10. Hooker W.D., Jones R.T. Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication. Psychopharmacology. 91:1987;20-24.
11. 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic turnover and impairs spatial working memory in rats: blockade of dopaminergic effects by HA966. Neuropsychopharmacology. 16:1997;426-432.
12. Jentsch J.D., Redmond D.E. Jr., Elsworth J.D., Taylor J.R., Youngren K.D., Roth R.H. Enduring cognitive dysfunction and cortical dopamine deficits in monkeys after long-term administration of phencyclidine. Science. 277:1997;953-955.
13. Jentsch, J.D., Taylor, J.R. and Roth, R.H., Subchronic phencyclidine administration increases mesolimbic dopamine system responsivity and augments stress- and psychostimulant-induced hyperlocomotion, Neuropsychopharmacology, (1998) in press.
14. Jentsch J.D., Tran A.N., Le D., Youngren K.D., Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology. 17:1997;92-99.
15. 9-tetrahydrocannabinol (THC) on memory in the rat. Drug Alcohol Depend. 28:1991;167-175.
16. Pope H.C., Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. J. Am. Med. Assoc. 21:1996;521-527.
17. Sawaguchi T., Goldman-Rakic P.S. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science. 251:1991;947-950.
18. Tunving K. Psychiatric effects of cannabis use. Acta Psychiatr. Scand. 72:1985;209-217.
19. Weinberger D.R., Berman K.F. Prefrontal function in schizophrenia: confounds and controversies. Phil. Trans. R. Soc. Lond. B. 351:1996;1495-1503.
20. Weinberger D.R., Berman K.F., Illowsky B.P. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch. Gen. Psychiatry. 45:1988;609-615.